-
Signature
-
/s/ James J. Comitale as Attorney-In-Fact
-
Stock symbol
-
OLLI
-
Transactions as of
-
Jun 3, 2024
-
Transactions value $
-
-$510,510
-
Form type
-
4
-
Date filed
-
6/5/2024, 05:03 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
OLLI |
Common Stock, par value $0.01 per share |
Options Exercise |
$8.3K |
+200 |
+1.89% |
$41.49 |
10.8K |
Jun 3, 2024 |
Direct |
F1 |
transaction |
OLLI |
Common Stock, par value $0.01 per share |
Sale |
-$16.9K |
-200 |
-1.85% |
$84.50 |
10.6K |
Jun 3, 2024 |
Direct |
F2 |
transaction |
OLLI |
Common Stock, par value $0.01 per share |
Options Exercise |
$470K |
+11.3K |
+106.88% |
$41.49 |
22K |
Jun 5, 2024 |
Direct |
F1 |
transaction |
OLLI |
Common Stock, par value $0.01 per share |
Sale |
-$972K |
-11.3K |
-51.66% |
$85.75 |
10.6K |
Jun 5, 2024 |
Direct |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
OLLI |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-200 |
-1.3% |
$0.00 |
15.2K |
Jun 3, 2024 |
Common Stock |
200 |
$41.49 |
Direct |
F1, F4 |
transaction |
OLLI |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-11.3K |
-74.67% |
$0.00 |
3.85K |
Jun 5, 2024 |
Common Stock |
11.3K |
$41.49 |
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: